about
A hidden Markov model for single particle tracks quantifies dynamic interactions between LFA-1 and the actin cytoskeletonDetection of cellular sialic acid content using nitrobenzoxadiazole carbonyl-reactive chromophores.Analysis of molecular diffusion by first-passage time variance identifies the size of confinement zonesStructural basis for substrate specificity of mammalian neuraminidases.Analysis of two-dimensional dissociation constant of laterally mobile cell adhesion moleculesDetection of Diffusion Heterogeneity in Single Particle Tracking Trajectories Using a Hidden Markov Model with Measurement Noise Propagation.Enhanced Cross-Linking of Diazirine-Modified Sialylated Glycoproteins Enabled through Profiling of Sialidase Specificities.T cell adhesion mechanisms revealed by receptor lateral mobility.Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012Screening Glycolipids Against Proteins in Vitro Using Picodiscs and Catch-and-Release Electrospray Ionization-Mass Spectrometry.Protecting group-free immobilization of glycans for affinity chromatography using glycosylsulfonohydrazide donors.Sialidase NEU4 is involved in glioblastoma stem cell survival.Mycobacterial phenolic glycolipids with a simplified lipid aglycone modulate cytokine levels through Toll-like receptor 2.Glycoform remodeling generates a synthetic T cell phenotype.Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU47,7'-(3,3'-Dibenzyl-3H,3'H-4,4'-bi-1,2,3-triazole-5,5'-di-yl)bis-(4-methyl-2H-chromen-2-one).5-(1-Benzyl-1H-1,2,3-triazol-4-yl)-2,1,3-benzoxadiazole5-(4-Hexyl-1H-1,2,3-triazol-1-yl)-2,1,3-benzoxadiazole.1-[1-(2,1,3-Benzoxadiazol-5-ylmeth-yl)-1H-1,2,3-triazol-4-yl]hexan-1-one.Galectin-3 alters the lateral mobility and clustering of β1-integrin receptors.A protected l-bromophosphonomethylphenylalanine amino acid derivative (BrPmp) for synthesis of irreversible protein tyrosine phosphatase inhibitors.Immobilization of carbohydrate epitopes for surface plasmon resonance using the Staudinger ligation.Positive regulation of insulin signaling by neuraminidase 1.A modular synthesis of alkynyl-phosphocholine headgroups for labeling sphingomyelin and phosphatidylcholine.Designed potent multivalent chemoattractants for Escherichia coli.Selective immobilization of multivalent ligands for surface plasmon resonance and fluorescence microscopy.Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.Visualization and characterization of receptor clusters by transmission electron microscopy.Mapping substrate interactions of the human membrane-associated neuraminidase, NEU3, using STD NMR.Substrate recognition of the membrane-associated sialidase NEU3 requires a hydrophobic aglycone.Construction of Multivalent Homo- and Heterofunctional ABO Blood Group Glycoconjugates Using a Trifunctional Linker Strategy.ABH-Glycan Microarray Characterizes ABO Subtype Antibodies: Fine Specificity of Immune Tolerance After ABO-Incompatible Transplantation.Human Neuraminidase Isoenzymes Show Variable Activities for 9-O-Acetyl-sialoside Substrates.Protein-glycosphingolipid interactions revealed using catch-and-release mass spectrometry.Selective Inhibitors of Human Neuraminidase 3.Conjugation of A and B Blood Group Structures to Silica Microparticles for the Detection of Antigen-Specific B Cells.Integrin-mediated cell migration is blocked by inhibitors of human neuraminidase.Practical labeling methodology for choline-derived lipids and applications in live cell fluorescence imaging.Conjugation of synthetic N-acetyl-lactosamine to azide-containing proteins using the Staudinger ligation.Picodiscs for facile protein-glycolipid interaction analysis.
P50
Q28471804-BE5B94D1-1393-48CA-8788-EFD8DB50EEDEQ34144637-AB1DFD8D-DE1E-4718-8468-5542B7DE76B3Q34690195-21C05870-6E2F-4E8B-9D90-7C6DFFB8EFBDQ35252939-1CDA9B15-0139-427A-8CA5-E1DF93CDCE0AQ35606770-700AFFEE-89AD-48B4-BA59-D06A0CA9243CQ35809953-46DC2869-5A11-48EC-8C6D-2D8696FE2574Q36514827-D8BCD3E6-A3CB-474E-8AF0-647420AB9001Q37015638-BD0EADBA-7F2D-4CB6-8A70-DC8E0A67B7C1Q37214705-C640E5DE-09B5-4DE3-AB2A-8FF475B76F11Q38292960-C8C075C7-F366-4732-AEC2-A36A5CED9775Q38296065-0486DD7D-910C-4318-8498-E4487B5E5A82Q38964051-95A22D61-9E3D-4255-90BE-82D19F534388Q39081826-3053B3F3-B9C0-4534-987F-A2C180A2CB8EQ39143191-599B813B-7D03-42F3-9914-4812BAFFE14CQ39780477-A249DB6B-771D-4E14-8753-F8D289647A94Q41807004-C56E94C2-11F9-4720-8539-6B83E644890FQ41948556-761A5BF7-AEAE-40CA-853E-1D2BAF83BDE6Q42135319-4265D93E-198C-431A-934C-B6903BEDD838Q42255565-E24FAFE8-154A-41F8-A081-3BBB15B442E1Q42706786-7F4815C0-DD2D-4070-BA89-98336F94F646Q42833747-625783C6-317E-4C8C-B429-1410F3EFE067Q42849364-BC2B1604-577D-4508-9DEB-A5C270779E3EQ43090881-C1025B03-0561-484E-9642-20B4F57CFD28Q43254130-FBEDBBBC-7008-499D-98DD-86F51369878DQ43735063-6589AA52-8C78-4B1E-A1A6-02BC9941864EQ44020630-4961B008-4955-4BBF-AF03-BC3E1FE4BAEEQ44573887-C753099E-E07F-48BF-B4ED-9D7EE06E634BQ44581081-08570483-C990-4D16-B170-D2F57BC4FF3FQ45335170-1BBE0252-9854-494E-AAC2-E77898AECF2BQ46860014-E07602FD-F248-425A-99B5-B8C52D80CEE5Q48123742-3A4D1C0C-41A3-4C90-859C-C24E13DD3254Q48912185-7D109BED-4832-4C96-A6E8-B4E0C0208E44Q50005340-DBD8B687-ECD9-4108-8E71-F0A3E1D413F9Q50058592-0DFB174B-AB3F-4586-9FAB-580D6982E5A1Q50100278-E9D48224-8987-4955-AAA8-0B4CFA277CD2Q51545172-196BB9E9-5046-4C8B-8361-4C55B94C4C5EQ51681697-BDB10B26-6F25-4DC7-8C68-75C9373CD95CQ51761886-17C2F363-23B9-4B95-83D2-DD92193B2894Q52709493-9B506BEB-189F-43A7-A32D-E8E60FB7AAE2Q53567404-2D5F2975-8443-478F-8628-5455559327EE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher W. Cairo
@ast
Christopher W. Cairo
@en
Christopher W. Cairo
@es
Christopher W. Cairo
@nl
Christopher W. Cairo
@sl
type
label
Christopher W. Cairo
@ast
Christopher W. Cairo
@en
Christopher W. Cairo
@es
Christopher W. Cairo
@nl
Christopher W. Cairo
@sl
prefLabel
Christopher W. Cairo
@ast
Christopher W. Cairo
@en
Christopher W. Cairo
@es
Christopher W. Cairo
@nl
Christopher W. Cairo
@sl
P1053
B-5355-2009
P106
P1153
6701726239
P21
P31
P3829
P496
0000-0003-3363-8708